Amedisys (AMED) Moves to Highs of Session Following Better-than-Expected Results
Tweet Send to a Friend
Amedisys (NASDAQ: AMED) is gaining momentum amid today's stronger-than-expected Q2 results. Shares are now up 17% on heavy volume.Amedisys ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
